NCLT sees violation of Sec 29(A) in Sterling Biotech case

For the second time, the NCLT has questioned the motive of Sterling Biotech's lenders, led by Andhra Bank.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2HT6JcK
via IFTTT